Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. 2002

Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
Medical Research Council Centre for Immune Regulation, University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom.

Exceptionally germinal center formation can be induced without T cell help by polysaccharide-based antigens, but these germinal centers involute by massive B cell apoptosis at the time centrocyte selection starts. This study investigates whether B cells in germinal centers induced by the T cell-independent antigen (4-hydroxy-3-nitrophenyl)acetyl (NP) conjugated to Ficoll undergo hypermutation in their immunoglobulin V region genes. Positive controls are provided by comparing germinal centers at the same stage of development in carrier-primed mice immunized with a T cell-dependent antigen: NP protein conjugate. False positive results from background germinal centers and false negatives from non-B cells in germinal centers were avoided by transferring B cells with a transgenic B cell receptor into congenic controls not carrying the transgene. By 4 d after immunization, hypermutation was well advanced in the T cell-dependent germinal centers. By contrast, the mutation rate for T cell-independent germinal centers was low, but significantly higher than in NP-specific B cells from nonimmunized transgenic mice. Interestingly, a similar rate of mutation was seen in extrafollicular plasma cells at this stage. It is concluded that efficient activation of hypermutation depends on interaction with T cells, but some hypermutation may be induced without such signals, even outside germinal centers.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007135 Immunoglobulin Variable Region That region of the immunoglobulin molecule that varies in its amino acid sequence and composition, and comprises the binding site for a specific antigen. It is located at the N-terminus of the Fab fragment of the immunoglobulin. It includes hypervariable regions (COMPLEMENTARITY DETERMINING REGIONS) and framework regions. Variable Region, Ig,Variable Region, Immunoglobulin,Framework Region, Immunoglobulin,Fv Antibody Fragments,Fv Fragments,Ig Framework Region,Ig Variable Region,Immunoglobulin Framework Region,Immunoglobulin Fv Fragments,Immunoglobulin V,Antibody Fragment, Fv,Antibody Fragments, Fv,Fragment, Fv,Fragment, Fv Antibody,Fragment, Immunoglobulin Fv,Fragments, Fv,Fragments, Fv Antibody,Fragments, Immunoglobulin Fv,Framework Region, Ig,Framework Regions, Ig,Framework Regions, Immunoglobulin,Fv Antibody Fragment,Fv Fragment,Fv Fragment, Immunoglobulin,Fv Fragments, Immunoglobulin,Ig Framework Regions,Ig Variable Regions,Immunoglobulin Framework Regions,Immunoglobulin Fv Fragment,Immunoglobulin Variable Regions,Regions, Immunoglobulin Variable,Variable Regions, Ig,Variable Regions, Immunoglobulin
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009596 Nitrophenols PHENOLS carrying nitro group substituents. Nitrophenol
D010648 Phenylacetates Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID. Benzeneacetates,Benzeneacetic Acids,Phenylacetic Acids,Acids, Benzeneacetic,Acids, Phenylacetic
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA

Related Publications

Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
April 1997, Annals of the New York Academy of Sciences,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
March 2024, Trends in immunology,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
May 2007, Journal of clinical pathology,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
November 2001, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
March 2022, The Journal of experimental medicine,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
April 1998, Immunological reviews,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
October 2014, Blood,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
February 2016, Genome medicine,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
January 1976, Advances in experimental medicine and biology,
Kai-Michael Toellner, and William E Jenkinson, and Dale R Taylor, and Mahmood Khan, and Daniel M-Y Sze, and David M Sansom, and Carola G Vinuesa, and Ian C M MacLennan
August 2013, Science (New York, N.Y.),
Copied contents to your clipboard!